Featured Posts
Recent Posts
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Classic
  • Twitter Classic
  • Google Classic

Jeffrey Friedland to Participate in the Cowen and Company Cannabis Colloquium

December 31, 2016

Jeffrey Friedland, author of “Marijuana: The World’s Most Misunderstood Plant,” will be participating as a panelist on the Policy Panel at the Cowen and Company Cannabis Colloquium. The event will be held on Thursday, January 12th in New York.

 

Cowen and Company is a research driven, growth oriented investment banking, providing debt and equity financing capabilities, strategic advice, research, and sales and trading services.

 

Friedland, who is also the CEO of INTIVA Inc., and Managing Director of Friedland Global Capital will be providing event attendees with copies of his book, “Marijuana: The World’s Most Misunderstood Plant.”

 

The Colloquium will be hosted by Vivien Azer, Cowen’s Lead Beverage, Tobacco, and Cannabis Analyst. The event will explore the growing cannabis markets. It will provide an industry overview, the exploration of regulatory issues, and insights into the operation of grows, concentrate manufacturing, dispensaries and accessory shops.

 

Positioned as a leading industry event, the Colloquium will include presentations, fireside chats, and panels, to an audience of institutional investors and private equity funds.

 

Jeffrey Friedland will be joined on the Policy Panel by Michael Safir of High Times Magazine and Allen St. Pierre, the Executive Director of the National Organization for the Reform of Marijuana Laws (NORML).

 

About Cowen and Company

 

Cowen and Company offers comprehensive investment banking services, including equity, equity-linked and debt financings and mergers and acquisitions advisory services. In addition, the firm offers its clients access to world-class research, institutional sales and trading services and a comprehensive suite of prime brokerage services.

Drawing upon the depth of Cowen’s research and industry knowledge, the firm specializes in the key areas of growth of the U.S. economy. The firm’s industry sector expertise includes Healthcare, Technology, Media and Telecommunications (TMT), Information and Technology Services, Consumer, Energy, Aerospace & Defense/Industrials, Transportation and Real Estate. In addition, Cowen offers extensive and focused aftermarket trading services as a leading market maker in its target sectors.

While Cowen’s principal product is knowledge, meeting the demands of its clients is its first order of business. The firm is convinced that the fundamental tenets that served us so well in the past century – uncompromising service, time-honored ethics, and a dedication to helping clients capitalize on change – will serve Cowen well in this century.

About Jeffrey Friedland

 

Jeffrey Friedland is an emerging market pioneer -- his firm, Friedland Global Capital, was one of the first American investment banks to establish a presence in China -- and is now on the front lines of the cannabis industry as an investor and business owner.  

 

In his book, Marijuana, the World's Most Misunderstood Plant, Mr. Friedland dives into the world of marijuana, discussing what we know and what we still hope to discover.

 

Mr. Friedland was an owner of two retail marijuana stores in Colorado which were located in the mountain resort towns of Breckenridge and Crested Butte, and a marijuana cultivation facility south of Steamboat Springs, which were featured in CNN's eight-part, reality series, High Profits.  

 

 

He is also CEO of privately-held INTIVA Inc., which has operating businesses and investments in the cannabis industry in California, Colorado, Israel, and Canada.

 

Mr. Friedland is a founder and early-stage investor in Israel-based, Israel Plant Sciences Ltd. (IPS), a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies. The company has four subsidiaries in Israel, with a focus on cannabis.

 

He is a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel.

 

Mr. Friedland is a member of the advisory board of OWC Pharmaceutical Research (OWCP). INTIVA Inc. made an early-stage investment in OWC Pharmaceutical Research during the summer of 2014.

 

Jeffrey Friedland is also the CEO of Friedland Capital, which was formed in 1982.

 

Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director and chairman of the audit committee of a New York Stock Exchange listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.

 

He is an author, speaker and thought leader on emerging markets, the global economy and the cannabis industry.

 

Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.

 

Friedland is a regular contributor to the monthly CannaInvestor Magazine.

 

Contact Information:

 

Jeffrey Friedland

Tel. 1 646 450 8909

Twitter jeff_friedland

Email jeffrey@jeffreyfriedland.com

Website/Blog www.jeffreyfriedland.com

Amazon Author Page http://tinyurl.com/naqzfgp





 

Please reload

FOLLOW ME

  • Facebook Classic
  • Twitter Classic

© 2020 Jeffrey Friedland - All Rights Reserved